TYMS and DPYD polymorphisms in a Turkish population

Clinical application of pharmacogenetics

Brian B. Spear, Margo Heath‐Chiozzi, Jeffrey Huff · Trends in Molecular Medicine · 2001 · 651 citations

Medicine, Pharmacology, Pharmacotherapy +12

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

Sheeja T. Pullarkat, Jan Stoehlmacher, Viviane S. Ghaderi et al. · The Pharmacogenomics Journal · 2001 · 573 citations

Medicine, Genetics, Oncology +13

Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.

Nobuyuki Horie, Hideo Aiba, Katsuhiko Oguro et al. · Cell Structure and Function · 1995 · 550 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Population study of dihydropyrimidine dehydrogenase in cancer patients.

M C Etienne, J.-L. Lagrange, O. Dassonville et al. · Journal of Clinical Oncology · 1994 · 432 citations

Medicine, Oncology, Pharmacology +15

Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.

Xiaoxiong Wei, Howard L. McLeod, J McMurrough et al. · Journal of Clinical Investigation · 1996 · 360 citations · Full text

Life Sciences, Genetics, Oncology +17